| | Study | | Tumour type | Procedure type | Morbidity | Mortality | 5-year survival | LR rate | Adverse prognostic features |
| | Austin and Solomon [31] | 36 | All pelvic | All | 70% | 0% | 69% | 28% | n/a | | Bakx et al. [43] | 40 | Rec. rectal | All | 83% | 6% | 28% | n/a | Positive CRM, symptomatic recurrence at surgery, peripheral recurrence | | Bannura et al. [44] | 30 | 1° rectal | PPE | 50% | 0% | 48% | 30% | n/a | | Derici et al. [40] | 57 | 1° rectal | All | 32% | 3.5% | 49% | 18% | Positive CRM, node positive | | Eckhauser et al. [45] | 12 | 1° rectal | PPE, TPE | 75% | 8% | 50% | 36% | n/a | | Ferenschild et al. [46] | 69 | All pelvic | TPE | 67% | 0% | 38% | 30% | Positive CRM | | Ferenschild et al. [47] | 25 | 1° and rec. rectal | All and sacrectomy | 68% | 0% | 30% | 66% | Node positive, positive CRM | | Gannon et al. [7] | 45 | 1° and rec. rectal | PPE, TPE | 47% | 0% | 52% | 22% | n/a | | Harris et al. [12] | 42 | 1° rectal | PPE, TPE | 49% | 0% | 48% | 7% | Metastases, node positive, EMVI | | Ike et al. [48] | 71 | 1° rectal | TPE | 66% | 4% | 54% | 28% | Age, tumour stage, node positive, | | Ishiguro et al. [49] | 91 | 1° rectal | PPE,TPE | 41% | 2% | 52% | 54% | Lateral pelvic LN positivity, raised CEA, EMVI | | Larsen et al. [41] | 124 | 1° rectal | PPE, TPE | 41% | 2.5% | 52% | 15% | Age, annular tumour, poor differentiation, pelvis side wall resection, transfusion | | Law et al. [50] | 24 | 1° and rec. rectal | All | 54% | 0% | 44% | n/a | n/a | | Maetani et al. [51] | 61 | Rec. rectal | All | n/a | 3% | 28% | 41% | n/a | | Melton et al. [52] | 29 | Rec. rectal | TPE and sacrectomy | 59% | 3.5% | 20% | 85% | Transfusion, positive CRM, bone invasion, anterior organ invasion | | Moriya et al. [53] | 128 | 1° rectal | All | 27% | 1% | 57% | 34% | BMI, node positive, inflammatory reaction | | Nguyen et al. [11] | 76 | All pelvic | All | 28% | 0% | 53% | n/a | n/a | |
Roos et al. [54] | 35 | 1° and rec. rectal | All | 69% | 3% | 52% | 12% | Positive CRM, preoperative pain | | Verschueren et al. [55] | 11 | 1° rectal | PPE, TPE | 27% | 9% | 68% | 9% | n/a | | Wiig et al. [56] | 6 | 1° rectal | LAR/APR and prostatectomy | 66% | 0% | 83% | n/a | n/a | | Påhlman et al. [33] | 28 | All pelvic | All | 54% | 7% | n/a | n/a | n/a | | Yamada et al. [5] | 64 | 1° and rec. rectal | TPE, PPE, and sacrectomy | 56% | 2% | 39% | n/a | n/a |
|
|
APE: anterior pelvic exenteration, PPE: posterior pelvic exenteration, TPE: total pelvic exenteration, All: APE, PPE, TPE, LAR: low anterior resection, APR: abdominoperineal.
|
